| Assessment of quality-of-life outcomes MA Testa, DC Simonson New England journal of medicine 334 (13), 835-840, 1996 | 4097 | 1996 |
| Type 2 diabetes mellitus RA DeFronzo, E Ferrannini, L Groop, RR Henry, WH Herman, JJ Holst, ... Nature reviews Disease primers 1 (1), 1-22, 2015 | 2219 | 2015 |
| The effects of antihypertensive therapy on the quality of life SH Croog, S Levine, MA Testa, B Brown, CJ Bulpitt, CD Jenkins, ... New England Journal of Medicine 314 (26), 1657-1664, 1986 | 1957 | 1986 |
| Discontinuation of antihyperlipidemic drugs—do rates reported in clinical trials reflect rates in primary care settings? SE Andrade, AM Walker, LK Gottlieb, NK Hollenberg, MA Testa, ... New England Journal of Medicine 332 (17), 1125-1131, 1995 | 634 | 1995 |
| Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial MA Testa, DC Simonson Jama 280 (17), 1490-1496, 1998 | 601 | 1998 |
| Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection LD Kaplan, DJ Straus, MA Testa, J Von Roenn, BJ Dezube, TP Cooley, ... New England Journal of Medicine 336 (23), 1641-1648, 1997 | 423 | 1997 |
| The risk of hospitalized infection in patients with rheumatoid arthritis. AL Smitten, HK Choi, MC Hochberg, S Suissa, TA Simon, MA Testa, ... The Journal of rheumatology 35 (3), 387-393, 2008 | 364 | 2008 |
| Quality of Life and Antihypertensive Therapy in Men--A Comparison of Captopril with Enalapril MA Testa, RB Anderson, JF Nackley, NK Hollenberg, ... New England journal of medicine 328 (13), 907-913, 1993 | 363 | 1993 |
| AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. SE Krown, MA Testa, J Huang Journal of Clinical Oncology 15 (9), 3085-3092, 1997 | 338 | 1997 |
| The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom AL Smitten, HK Choi, MC Hochberg, S Suissa, TA Simon, MA Testa, ... Arthritis Care & Research 57 (8), 1431-1438, 2007 | 318 | 2007 |
| Methods for quality-of-life studies. MA Testa, JF Nackley Annual review of public health 15, 535-559, 1994 | 300 | 1994 |
| Prevalence of noise-induced hearing-threshold shifts and hearing loss among US youths E Henderson, MA Testa, C Hartnick Pediatrics 127 (1), e39-e46, 2011 | 281 | 2011 |
| Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study NR Reynolds, MA Testa, LG Marc, MA Chesney, JL Neidig, SR Smith, ... AIDS and Behavior 8, 141-150, 2004 | 277 | 2004 |
| Prognostic value of the electroencephalogram in neonatal asphyxia G Holmes, J Rowe, J Hafford, R Schmidt, M Testa, A Zimmerman Electroencephalography and clinical neurophysiology 53 (1), 60-72, 1982 | 264 | 1982 |
| Higher survival rates among younger patients after pediatric intensive care unit cardiac arrests PA Meaney, VM Nadkarni, EF Cook, M Testa, M Helfaer, W Kaye, ... Pediatrics 118 (6), 2424-2433, 2006 | 232 | 2006 |
| The association of treatment‐related symptoms with quality‐of‐life outcomes for localized prostate carcinoma patients CG Bacon, E Giovannucci, M Testa, TA Glass, I Kawachi Cancer 94 (3), 862-871, 2002 | 204 | 2002 |
| Examining the effect of information channel on COVID-19 vaccine acceptance R Piltch-Loeb, E Savoia, B Goldberg, B Hughes, T Verhey, J Kayyem, ... Plos one 16 (5), e0251095, 2021 | 197 | 2021 |
| Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection WR Lenderking, RD Gelber, DJ Cotton, BF Cole, A Goldhirsch, ... New England Journal of Medicine 330 (11), 738-743, 1994 | 189 | 1994 |
| The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer CG Bacon, E Giovannucci, M Testa, I Kawachi The Journal of urology 166 (5), 1804-1810, 2001 | 187 | 2001 |
| Predictors of COVID-19 vaccine hesitancy: socio-demographics, co-morbidity, and past experience of racial discrimination E Savoia, R Piltch-Loeb, B Goldberg, C Miller-Idriss, B Hughes, ... Vaccines 9 (7), 767, 2021 | 175 | 2021 |
